Analyst Price Targets — RCEL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 15, 2026 11:45 am | — | Lake Street | $6.00 | $4.36 | TheFly | Avita Medical upgraded to Buy from Hold at Lake Street |
| March 26, 2026 2:17 pm | — | Northland Securities | $10.00 | $3.86 | TheFly | Avita Medical stock pullback creates buying opportunity, says Northland |
| January 16, 2026 1:35 pm | — | Lake Street | $3.50 | $3.60 | TheFly | Avita Medical price target raised to $3.50 from $3 at Lake Street |
| October 17, 2025 11:38 am | Frank Takkinen | Lake Street | $4.00 | $5.38 | TheFly | Avita Medical downgraded to Hold from Buy at Lake Street |
| January 8, 2025 2:00 pm | Brooks O'Neil | Lake Street | $14.00 | $14.06 | TheFly | Avita Medical price target lowered to $14 from $20 at Lake Street |
| May 14, 2024 3:04 am | Matt O'Brien | Piper Sandler | $9.00 | $8.35 | StreetInsider | Piper Sandler Downgrades Avita Medical Ltd. (RCEL) to Neutral |
Latest News for RCEL
VALENCIA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company delivering transformative solutions, today announced that it will report its second quarter 2026 financial results after the close of the U.S. financial markets on Thursday, August 6, 2026.
Avita Medical (RCEL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and…
AVITA Medical, Inc. (RCEL) Shareholder/Analyst Call Prepared Remarks Transcript
AVITA Medical, Inc. (RCEL) Discusses Business Progress, Operational Changes and Sequential Revenue Growth Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for RCEL.
U.S. House Trading
No House trades found for RCEL.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.